Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Mass General at North Shore Cancer Center, Danvers, MA
Breast Cancer+5 More
Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention - Behavioral
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.

Eligible Conditions

  • Breast Cancer
  • Refusal, Treatment
  • Survival Rate (Survivorship)
  • Compliance, Treatment
  • Treatment Adherence

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: Up to 3 months/12 weeks

Baseline (within 1-week of consent), 1-month, and 3-months post-baseline
Adjuvant endocrine therapy (AET) Initiation
Month 3
Program Acceptability
Program Feasibility

Trial Safety

Trial Design

1 Treatment Group

Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention · No Placebo Group · N/A

Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention
Behavioral
Experimental Group · 1 Intervention: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 3 months/12 weeks
Closest Location: Mass General at North Shore Cancer Center · Danvers, MA
Photo of massachusetts 1Photo of massachusetts 2Photo of massachusetts 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Breast Cancer
0 CompletedClinical Trials

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,660 Previous Clinical Trials
30,828,767 Total Patients Enrolled
76 Trials studying Breast Cancer
125,481 Patients Enrolled for Breast Cancer
Jamie M Jacobs, PhDPrincipal InvestigatorMassachusetts General Hospital

Eligibility Criteria

Age 18+ · Female Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have an Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2.
You are a member of a racial or ethnic minority community.
You must be 21 years of age or older to participate in this study.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.